Outcome (measurement unit) | Systematic review | Population | Comparison | Participants (included studies) | Effect size MD (95% CI) | Risk of bias | Certainty of evidence |
Heart rate (measured in beats per minute (bpm)) | Zheng et al12 | Healthy adults | Surgical mask versus no mask | 692 (28 RCTs/randomised crossover trials) | 0.96 (−1.01 to 2.93) | Moderate | ⊕⊕◯◯* Low |
N95 respirator versus no mask | 391 (18 RCTs/randomised crossover trials) | 1.63 (−2.79 to 6.05) | Moderate | ⊕⊕◯◯* Low | |||
Cloth mask versus no mask | 115 (5 crossover trials) | −0.94 (−6.39 to 4.52) | Moderate | ⊕⊕◯◯* Low | |||
Mask versus no mask (progressive exercise state) | 803 (31 RCTs/randomised crossover trials) | −0.74 (−4.48 to 2.99) | Moderate | ⊕⊕◯◯* Low | |||
Mask versus no mask (steady-state exercise) | 685 (25 RCTs/randomised crossover trials) | 2.69 (1.10 to 4.28) | Moderate | ⊕⊕◯◯* Low | |||
Chen et al32 | Patients with COPD | Face mask versus no mask | 97 (1 non-RCT) | 4.70 (−0.30 to 9.70) | Moderate | ⊕⊕◯◯† Low | |
Maximum heart rate | Chen et al32 | Patients with COPD | Face mask versus no mask | 27 (1 randomised crossover trial) | −1.90 (−10.84 to 7.04) | Moderate | ⊕◯◯◯† Very low |
Stroke volume (measured in millilitres (mL) per beat) | Shaw et al15 | Healthy adults | Face mask versus no mask | 26 (2 crossover trials) | 12.33 (−4.09 to 28.75) | Moderate | ⊕⊕◯◯‡ Low |
N95 respirator versus no mask | 14 (1 crossover trial) | 13.0 (−6.97 to 32.97) | Moderate | ⊕◯◯◯† Very low | |||
Cardiac output (measured in mL/min) | Shaw et al15 | Healthy adults | Face mask versus no mask | 26 (2 crossover trials) | 2.26 (−0.15 to 4.67) | Moderate | ⊕⊕◯◯‡ Low |
N95 respirator versus no mask | 14 (1 crossover trial) | 1.20 (−2.19 to 4.59) | Moderate | ⊕◯◯◯† Very low | |||
Systolic blood pressure (measured in millimetres of mercury (mm Hg)) | Shaw et al15 | Healthy adults | Face mask versus no mask | 1088 (4 crossover trials and 2 retrospective observational studies) | −2.23 (−5.28 to 0.82) | High | ⊕◯◯◯§ Very low |
N95 respirator versus no mask | 130 (3 randomised crossover trials and 1 RCT) | −0.12 (−4.22 to 3.97) | Moderate | ⊕⊕◯◯‡ Low | |||
Chen et al32 | Patients with COPD | Face mask versus no mask following 6MWT | 97 (1 non-RCT) | 0.40 (−4.36 to 5.16) | Moderate | ⊕⊕◯◯† Low | |
Face mask versus no mask following maximum exercise test | 27 (1 crossover trial) | −6.80 (−24.37 to 10.77) | Moderate | ⊕⊕◯◯† Low | |||
Diastolic blood pressure (measured in mm Hg) | Shaw et al15 | Healthy adults | Face mask versus no mask | 38 (3 crossover trials) | −0.96 (−5.32 to 3.40) | Moderate | ⊕⊕◯◯‡ Low |
N95 respirator versus no mask | 114 (2 crossover trials and 1 non-RCT) | −0.23 (−3.06 to 2.60) | Moderate | ⊕⊕◯◯‡ Low | |||
Chen et al32 | Patients with COPD | Face mask versus no mask at rest | 97 (1 non-RCT) | 2.70 (−0.34 to 5.74) | Moderate | ⊕⊕◯◯‡ Low | |
Face mask versus no mask following 6MWT | 97 (1 non-RCT) | −0.80 (−4.13 to 2.53) | Moderate | ⊕⊕◯◯‡ Low | |||
Mean arterial blood pressure (measured in mm Hg) | Lima et al31 | Adult patients | Face mask versus no mask | 116 (6 crossover trials) | −0.07 (−0.32 to 0.17) | High | ⊕◯◯◯§ Very low |
*Low quality of evidence is due to unexplained inconsistency and imprecise results due to small magnitude of change and wide CI.
†Low quality of evidence is due to imprecise results due to small magnitude of change and wide CI and some concern with risk of bias.
‡Low quality of evidence is due to imprecise results due to small magnitude of change and wide CI.
§Low quality of evidence is due to unexplained inconsistency and imprecise results due to small magnitude of change and wide CI and some concern with risk of bias.
COPD, chronic obstructive pulmonary disease; MD, mean difference; 6MWT, 6 min walk test; RCT, randomised controlled trial.